Nocturnal asthma: Underlying mechanisms and treatment

Current Allergy and Asthma Reports

Volumn 5, Issue 2, 2005, Pages 161-167

  Sutherland, E Rand ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIASTHMATIC AGENT; BECLOMETASONE; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUDESONIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; OXITROPIUM BROMIDE; PREDNISONE; SALBUTAMOL; SALMETEROL; THEOPHYLLINE; TRIAMCINOLONE;

AROUSAL; BRONCHUS HYPERREACTIVITY; CLINICAL TRIAL; COUGHING; DISEASE EXACERBATION; DRUG BLOOD LEVEL; DRUG HALF LIFE; DRUG MECHANISM; DYSPNEA; FORCED EXPIRATORY VOLUME; HUMAN; MEDICAL RESEARCH; NOCTURNAL ASTHMA; OPTIMAL DRUG DOSE; RESPIRATORY AIRFLOW; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIDE EFFECT;

EID: 14744293961     PISSN: 15297322     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11882-005-0091-z     Document Type: Review

References (45)

1. Turner-Warwick M: Epidemiology of nocturnal asthma. Am J Med 1988, 85:6-8.
2. Hetzel MR, Clark TJ, Branthwaite MA: Asthma: analysis of sudden deaths and ventilatory arrests in hospital. Br Med J 1977, 1:808-811.
3. Martin RJ: Location of airway inflammation in asthma and the relationship to circadian change in lung function. Chronobiol Int 1999, 16:623-630.
4. Van Keimpema AR, Ariaansz M, Tamminga JJ, et al.: Nocturnal waking and morning dip of peak expiratory flow in clinically stable asthma patients during treatment: occurrence and patient characteristics. Respiration 1997, 64:29-34.
5. Martin RJ, Cicutto LC, Ballard RD: Factors related to the nocturnal worsening of asthma. Am Rev Respir Dis 1990, 141: 3-38.
6. Kraft M, Djukanovic R, Wilson S, et al.: Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 1996, 154:1505-1510.
7. Dethlefsen U, Repgas R: Ein neues Therapieprinzip bei Nachtlichen Asthma. Klin Med 1985, 80:44-47.
8. Cochrane GM, Clark JH: A survey of asthma mortality in patients between ages 35 and 64 in the Greater London hospitals in 1971. Thorax 1975, 30:300-305.
9. Irvin CG, Pak J, Martin RJ: Airway-parenchyma uncoupling in nocturnal asthma. Am J Respir Crit Care Med 2000, 161: 0-56.
10. Kharitonov SA, Yates D, Robbins RA, et al.: Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994, 343:133-135.
11. ten Hacken NH, van der Vaart H, van der Mark TW, et al. Exhaled nitric oxide is higher both at day and night in subjects with nocturnal asthma. Am J Respir Crit Care Med 1998, 158: 02-907.
12. Georges G, Bartelson BB, Martin RJ, Silkoff PE: Circadian variation in exhaled nitric oxide in nocturnal asthma. J Asthma 1999, 36:467-473.
13. Silkoff PE, McClean PA, Slutsky AS, et al.: Exhaled nitric oxide and bronchial reactivity during and after inhaled beclomethasone in mild asthma. J Asthma 1998, 35:473-479.
14. Kraft M, Martin RJ, Wilson S, et al.: Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 1999, 159:228-234.
15. Djukanovic R, Roche WR, Wilson JW, et al.: Mucosal inflammation in asthma. Am Rev Respir Dis 1990, 142: 34-457.
16. Szefler SJ, Ando R, Cicutto LC, et al.: Plasma histamine, epinephrine, cortisol, and leukocyte beta-adrenergic receptors in nocturnal asthma. Clin Pharmacol Ther 1991, 49:59-68.
17. Turki J, Pak J, Green SA, et al.: Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonnocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype. J Clin Invest 1995, 95:1635-1641.
18. Kraft M, Vianna E, Martin RJ, Leung DYM: Nocturnal asthma is associated with reduced glucocorticoid receptor binding affinity and decreased steroid responsiveness at night. J Allergy Clin Immunol 1999, 103:66-71.
19. Kraft M, Leung DYM, Martin RJ, Hamid QA: Reduced steroid responsiveness at night in asthma is due to increased glucocorticoid receptor beta expression in lung macrophages. Am J Respir Crit Care Med 1999, 159:A632.
20. Sutherland ER, Ellison MC, Kraft M, Martin RJ: Altered pituitary-adrenal interaction in nocturnal asthma. J Allergy Clin Immunol 2003, 112:52-57.
21. Sutherland ER, Martin RJ, Ellison MC, Kraft M: Immunomodulatory effects of melatonin in asthma. Am J Respir Crit Care Med 2002, 166:1055-1061.
22. Sutherland ER, Ellison MC, Kraft M, Martin RJ: Elevated serum melatonin is associated with the nocturnal worsening of asthma. J Allergy Clin Immunol 2003, 112:513-517.
23. Guidelines for the diagnosis and management of asthma: Report No. 97-4051. Bethesda, MD: National Heart, Lung and Blood Institute; 1997.
24. Wempe JB, Tammeling EP, Postma DS, et al.: Effects of budesonide and bambuterol on circadian variation of airway responsiveness and nocturnal symptoms of asthma. J Allergy Clin Immunol 1992, 90:349-357.
25. Toogood JH, Baskerville JC, Jennings B, et al.: Influence of dosing frequency and schedule on the response of chronic asthmatics to the aerosol steroid, budesonide. J Allergy Clin Immunol 1982, 70:288-298.
26. Malo JL, Cartier A, Merland N, et al.: Four-times-a-day dosing frequency is better than a twice-a-day regimen in subjects requiring a high-dose inhaled steroid, budesonide, to control moderate to severe asthma. Am Rev Respir Dis 1989, 140: 24-628.
27. Horn CR, Clark TJ, Cochrane GM: Inhaled therapy reduces morning dips in asthma. Lancet 1984, 1:1143-1145.
28. Pincus DJ, Szefler SJ, Ackerson LM, Martin RJ: Chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1995, 95: 172-1178.
29. Pincus DJ, Humeston TR, Martin RJ: Further studies on the chronotherapy of asthma with inhaled steroids: the effect of dosage timing on drug efficacy. J Allergy Clin Immunol 1997, 100: 71-774.
30. Reinberg A, Gervais P, Chaussade M, et al.: Circadian changes in effectiveness of corticosteroids in eight patients with allergic asthma. J Allergy Clin Immunol 1983, 71: 25-433.
31. Reinberg A, Halberg F, Falliers CJ: Circadian timing of methylprednisolone effects in asthmatic boys. Chronobiologia 1974, 1:333-347.
32. Beam WR, Weiner DE, Martin RJ: Timing of prednisone and alterations of airways inflammation in nocturnal asthma. Am Rev Respir Dis 1992, 146:1524-1530.
33. Fitzpatrick MF, Mackay T, Driver H, Douglas NJ: Salmeterol in nocturnal asthma: a double blind, placebo controlled trial of a long acting inhaled beta 2 agonist. BMJ 1990, 301:1365-1368.
34. Lockey RF, DuBuske LM, Friedman B, et al.: Nocturnal asthma: effect of salmeterol on quality of life and clinical outcomes. Chest 1999, 115:666-673.
35. Barnes PJ, Greening AP, Neville L, et al.: Single-dose slow-release aminophylline at night prevents nocturnal asthma. Lancet 1982, 1:299-301.
36. Goldenheim PD, Conrad EA, Schein LK: Treatment of asthma by a controlled-release theophylline tablet formulation: a review of the North American experience with nocturnal dosing. Chronobiol Int 1987, 4:397-408.
37. Martin RJ, Cicutto LC, Ballard RD, et al.: Circadian variations in theophylline concentrations and the treatment of nocturnal asthma. Am Rev Respir Dis 1989, 139:475-478.
38. Elias-Jones AC, Higenbottam TW, Barnes ND, Godden DJ: Sustained release theophylline in nocturnal asthma. Arch Dis Child 1984, 59:1159-1161.
39. Coe CI, Barnes PJ: Reduction of nocturnal asthma by an inhaled anticholinergic drug. Chest 1986, 90:485-488.
40. Chan CS, Woolcock AJ, Sullivan CE: Nocturnal asthma: role of snoring and obstructive sleep apnea. Am Rev Respir Dis 1988, 137:1502-1504.
41. Martin RJ, Pak J: Nasal CPAP in nonapneic nocturnal asthma. Chest 1991, 100:1024-1027.
42. Martin RJ, Kraft M: Nocturnal asthma: therapeutic considerations. Clin Immunother 1996, 6:443-453.
43. Tan WC, Martin RJ, Pandey R, Ballard RD: Effects of spontaneous and simulated gastroesophageal reflux on sleeping asthmatics. Am Rev Respir Dis 1990, 141:1394-1399.
44. Brugman SM, Larsen GL, Henson PM, et al.: Increased lower airways responsiveness associated with sinusitis in a rabbit model. Am Rev Respir Dis 1993, 147:314-320.
45. Shturman-Ellstein R, Zeballos RJ, Buckley JM, Souhrada JF: The beneficial effect of nasal breathing on exercise-induced bronchoconstriction. Am Rev Respir Dis 1978, 118:65-73.